MiniMed Group, Inc. (MMED) Balance Sheet
MMED balance sheet, FY2026
April 30, 2026 · U.S. dollars$4.63B assets = $1.02B liabilities + $3.61B equity
Both columns are drawn to the same scale: what MMED owns equals what it owes plus shareholders’ equity. Hover a block for its value.
MMED financial health
Descriptive bands, not a rating. Fiscal FY2026.
MMED balance sheet trends, FY2024–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $4.09BFY2024 | $4.63BFY2026 | +6.3%/yr | |
| Total liabilities | $646.0MFY2024 | $1.02BFY2026 | +25.6%/yr | |
| Shareholders’ equity | $3.45BFY2024 | $3.61BFY2026 | +2.3%/yr | |
| Cash & short-term investments | $54.0MFY2024 | $298.0MFY2026 | +134.9%/yr | |
| Total debt | $8.0MFY2024 | $145.0MFY2026 | +325.7%/yr | |
| Net cash (debt) | $46.0MFY2024 | $153.0MFY2026 | +$107.0M | |
| Working capital | $377.0MFY2024 | $646.0MFY2026 | +$269.0M | |
| Book value per share | $12.28FY2024 | $14.07FY2026 | +7.1%/yr | |
| Current ratio | 1.73FY2024 | 1.92FY2026 | +0.19 | |
| Debt / equity | 0.00FY2024 | 0.04FY2026 | +0.04 | |
| Shares outstanding | 280.8MFY2024 | 256.6MFY2026 | −4.4%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
MMED assets
MMED liabilities and equity
MMED debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
MMED balance sheet
| FY2026 | FY2025 | FY2024 | |
|---|---|---|---|
| Assets | |||
| Cash & short-term investments | $298.0M | $11.0M | $54.0M |
| Cash & equivalents | $298.0M | $11.0M | $54.0M |
| Receivables | $655.0M | $570.0M | $507.0M |
| Inventory | $341.0M | $310.0M | $292.0M |
| Other current assets | $54.0M | $48.0M | $42.0M |
| Total current assets | $1.35B | $939.0M | $895.0M |
| Property, plant & equipment (net) | $711.0M | $706.0M | $636.0M |
| Goodwill & intangible assets | $2.36B | $2.39B | $2.42B |
| Long-term investments | $0 | $0 | $0 |
| Other non-current assets | $209.0M | $170.0M | $148.0M |
| Total assets | $4.63B | $4.20B | $4.09B |
| Liabilities | |||
| Accounts payable | $163.0M | $205.0M | $190.0M |
| Short-term debt | $145.0M | $11.0M | $8.0M |
| Deferred revenue | $15.0M | $11.0M | $11.0M |
| Total current liabilities | $702.0M | $710.0M | $518.0M |
| Long-term debt | $0 | $0 | $0 |
| Lease obligations | $8.0M | $11.0M | $8.0M |
| Other long-term liabilities | $317.0M | $160.0M | $128.0M |
| Total liabilities | $1.02B | $870.0M | $646.0M |
| Shareholders' equity | |||
| Common stock & paid-in capital | $3.0M | — | — |
| Retained earnings (deficit) | −$116.0M | $0 | — |
| Accumulated other comprehensive income | −$12.0M | $3.0M | −$16.0M |
| Minority interest | $0 | $0 | — |
| Total shareholders' equity | $3.61B | $3.33B | $3.45B |
| Key figures | |||
| Total debt | $145.0M | $11.0M | $8.0M |
| Net cash (debt) | $153.0M | $0 | $46.0M |
| Working capital | $646.0M | $229.0M | $377.0M |
| Tangible book value | $1.25B | $945.0M | $1.03B |
| Book value per share | $14.07 | $11.86 | $12.28 |
| Shares outstanding | 256.6M | 280.8M | 280.8M |
| Current ratio | 1.92 | 1.32 | 1.73 |
| Quick ratio | 1.36 | 0.82 | 1.08 |
| Debt / equity | 0.04 | 0.00 | 0.00 |
| Equity / assets | 78.0% | 79.3% | 84.2% |
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Apr '25 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & short-term investments | $207.0M | $298.0M | $10.0M | $350.0M | $11.0M |
| Cash & equivalents | $207.0M | $298.0M | $10.0M | $350.0M | $11.0M |
| Receivables | $782.0M | $655.0M | $653.0M | $166.0M | $570.0M |
| Inventory | $356.0M | $341.0M | $407.0M | $362.0M | $310.0M |
| Other current assets | $72.0M | $54.0M | $38.0M | $13.0M | $48.0M |
| Total current assets | $1.42B | $1.35B | $1.11B | $891.0M | $939.0M |
| Property, plant & equipment (net) | $736.0M | $711.0M | $701.0M | $755.0M | $706.0M |
| Goodwill & intangible assets | $2.35B | $2.36B | $2.37B | $2.38B | $2.39B |
| Long-term investments | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $210.0M | $209.0M | $166.0M | $214.0M | $170.0M |
| Total assets | $4.72B | $4.63B | $4.34B | $4.24B | $4.20B |
| Liabilities | |||||
| Accounts payable | $251.0M | $163.0M | $303.0M | $129.0M | $205.0M |
| Short-term debt | $9.0M | $145.0M | $11.0M | — | $11.0M |
| Deferred revenue | — | $15.0M | $13.0M | — | $11.0M |
| Total current liabilities | $782.0M | $702.0M | $696.0M | $350.0M | $710.0M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $9.0M | $8.0M | $11.0M | — | $11.0M |
| Other long-term liabilities | $316.0M | $317.0M | $184.0M | $141.0M | $160.0M |
| Total liabilities | $1.10B | $1.02B | $880.0M | $491.0M | $870.0M |
| Shareholders' equity | |||||
| Common stock & paid-in capital | $3.0M | $3.0M | — | $3.0M | — |
| Retained earnings (deficit) | −$116.0M | −$116.0M | — | −$5.0M | $0 |
| Accumulated other comprehensive income | −$14.0M | −$12.0M | $14.0M | $8.0M | $3.0M |
| Minority interest | — | $0 | — | — | $0 |
| Total shareholders' equity | $3.62B | $3.61B | $3.46B | $3.74B | $3.33B |
| Key figures | |||||
| Total debt | $59.0M | $145.0M | $11.0M | — | $11.0M |
| Net cash (debt) | $148.0M | $153.0M | −$1.0M | — | $0 |
| Working capital | $635.0M | $646.0M | $412.0M | $541.0M | $229.0M |
| Tangible book value | $1.26B | $1.25B | $1.09B | $1.37B | $945.0M |
| Book value per share | $12.88 | $13.47 | $12.33 | $13.33 | $11.86 |
| Shares outstanding | 281.0M | 268.1M | 280.8M | 280.8M | 280.8M |
| Current ratio | 1.81 | 1.92 | 1.59 | 2.55 | 1.32 |
| Quick ratio | 1.26 | 1.36 | 0.95 | 1.47 | 0.82 |
| Debt / equity | 0.02 | 0.04 | 0.00 | — | 0.00 |
| Equity / assets | 76.7% | 78.0% | 79.7% | 88.4% | 79.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed June 29, 2026); data from EODHD.
MMED financial position
At the end of fiscal 2026 (April 30, 2026), MiniMed had total assets of $4.6 billion (up 10.2% from a year earlier), total liabilities of $1.0 billion and shareholders' equity of $3.6 billion. It held $298.0 million in cash and short-term investments against $145.0 million of debt, a net cash position of $153.0 million. Its current ratio was 1.92. In the latest quarter (ended July 31, 2026) total assets were $4.7 billion and equity $3.6 billion.
Related: MMED income statement, MMED cash flow statement, MMED key metrics. See the MMED stock overview for the latest quote and news.
MMED balance sheet FAQ
What are MiniMed's total assets?
MiniMed reported total assets of $4.6 billion at the end of fiscal 2026 (April 30, 2026), compared with $4.2 billion a year earlier.
How much debt does MiniMed have?
MiniMed had $145.0 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.04.
How much cash does MiniMed have?
MiniMed held $298.0 million in cash and short-term investments at the end of fiscal 2026; with $145.0 million of debt that is net cash of $153.0 million.
What is MiniMed's book value?
MiniMed's shareholders' equity (book value) was $3.6 billion at the end of fiscal 2026, or $14.07 per share.
What is MiniMed's current ratio?
MiniMed had current assets of $1.3 billion and current liabilities of $702.0 million, a current ratio of 1.92 (it can cover its short-term obligations).
How much goodwill does MiniMed have?
MiniMed carried $2.4 billion of goodwill and intangible assets, 51.0% of total assets, at the end of fiscal 2026.